NSE's $2.3B IPO Prices 15-20% Below Roadshow Amid Derivatives Slowdown
CME sits 26% above its 52-week low of $218.31.
Summary
India's National Stock Exchange (NSE) launches its $2.3 billion IPO on Thursday with a price band of ₹1,700-₹1,785, valuing the exchange at $46 billion. That's 15-20% below the valuation sought in pre-deal roadshows and 40% below 2024 private market sales, reflecting investor caution over declining derivatives volumes. NSE's revenue fell 3.1% and profit dropped 15.5% in FY2026 as options trading volumes dropped 27% from their 2024 peak. The IPO is an offer-for-sale with no new capital raised, and anchor investors including ADIA, GIC, Fidelity, and Norges have committed. For CME Group, the world's largest derivatives exchange, this pricing signals a broader reassessment of exchange valuations amid regulatory pressure on options trading. CME is already fighting the CFTC over perpetual futures and facing a stay on its 24/7 crude oil contract. The NSE IPO's discounted valuation could pressure CME's own multiple, which currently trades at a premium to global peers. Watch for CME's response to the competitive and regulatory landscape as Indian derivatives normalize.
At the time of this announcement, CME was trading at $275.10 on NASDAQ in the Finance sector, with a market capitalization of approximately $98.9B. The 52-week trading range was $218.31 to $329.16. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Business Line.